SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15F-12B - Securities registration termination of foreign private issuers [Section 12(b)]:
SEC Accession No. 0001193125-24-064379
Filing Date
2024-03-11
Accepted
2024-03-11 08:31:57
Documents
3
Effectiveness Date
2024-03-11

Document Format Files

Seq Description Document Type Size
1 15F-12B d766992d15f12b.htm 15F-12B 24247
2 EX-99.1 d766992dex991.htm EX-99.1 13725
3 GRAPHIC g766992g0309012839757.jpg GRAPHIC 2836
  Complete submission text file 0001193125-24-064379.txt   43337
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
PHAXIAM Therapeutics S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 15F-12B | Act: 34 | File No.: 001-38281 | Film No.: 24736658
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)